The Study of the Hepatotrophic Factor in Seva from Patients with Fulminant Gepatic Failure. -its purification and clinical significarce-
The Study of the Hepatotrophic Factor in Seva from Patients with Fulminant Gepatic Failure. -its purification and clinical significarce-
批准号:
61480190
负责人:
HASHIMOT Shuji
金额:
$4.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1987
中文摘要
点击翻译按钮获取中文摘要
英文摘要
According to the initial plan, we studied the human hepatooytc growth factor (hHGF) and obtained the following results.(1) Liver cell growth was measured using adult rat liver celis in primary culture. inetoon of twenty sera or plasma from patients with fulminant hepatic failure. and serum from a patient with "acute on chronic" showed marked stimulatoy activity on DNA synthesis at about 5-50 times higher than an avarage value of normal human sera.(2) hHGF was purified at about 210,000-fold from heated plasma from patients with fulminant hepatic failure. The pulification invelves heat treatment of plasma ammonium sulfate precipitation. and column chromatographies on Affi-Gel Blue. hepalin-Sopharose. and hydroxylapatite.(3) Pulified hHGF shows several bands with molecular weights of about 80,000 on SDS-PAGE. Each bands shows growth-stimulating activity on cuitured hepatocytes which is propotional to the intensity of the band. After reduction of the sample with 2-mercptoethanol. SDS-PAGE yield two chaines with molecular weights of about 30,000 and 60,000.(4) hHGF stimulates growth of cultured rat hepatocytes more effectively than human epidermal growth factor(hHGF) or insulin. and the effect of hHGF is additive and synergistic with the maximal effects of hHGF and insulin. respectively. These results suggest that hHGF is a new growthfactor which is different from hHGF.(5) Recently. a monoclonal antibody to hHGF was raised using purified hHGF as antigen. At present we are studying the organ producing hHGF using with this antibody.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
橋本修治: 病態生理. 479-481 (1987)
桥本修二:病理生理学 479-481 (1987)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eichi, Gohda: J. Clin. Invest.81(2). 414-419 (1988)
Eichi, Gohda:J. Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S,Hashimoto: "Human Hepatocyte Growth Factor in Plasma from Patients with Fulminant Hepatic Failure." MEDICINA PHILOSOPHICA. 6. 479-481 (1987)
S,桥本:“暴发性肝衰竭患者血浆中的人肝细胞生长因子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eiichi,Gohda: "Purification and characterigation of hepatocyte growth factor from Plasma of a patient with fulminant hepatic failure" J. Clin. Invest.81(2). 414-419 (1988)
Eiichi,Gohda:“从暴发性肝衰竭患者血浆中纯化和表征肝细胞生长因子”J. Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eiichi Gohda: J.Clin.Invest.
Eiichi Gohda:J.Clin.Invest。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
海外基金